According to a new report, published by KBV research, The Global Dental Bone Grafts And Substitutes Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 8.0% CAGR during the forecast period.
The Hospitals segment is showcasing a CAGR of 10.5% during (2022 - 2028). The availability of a wide variety of reconstructive surgeries under these institutions is responsible for the rise. Some hospitals are self-funded and affiliated with tissue banks that strive to provide services that are at the top of their class. In addition, hospitals work closely with several insurance providers to ensure quick and efficient payment. Due to all these advantages, hospitals see greater total foot traffic than clinics.
The Xenograft segment acquired maximum revenue share in the Global Dental Bone Grafts and Substitutes Market by Material Type in 2021 thereby, achieving a market value of $541.3 million by 2028. A xenograft is a bone put into a human being that was obtained from an animal source, such as a bovine. Excellent osteoconductive qualities may be seen in these grafts. Bio-Oss is the most often utilized xenograft. To increase penetration, major companies in the market are launching new xenograft products.
The Ridge Augmentation segment has shown the growth rate of 8.2% during (2022 - 2028). The growth is due to the procedure's rapid healing period and lack of discomfort. Ridge augmentation enlarges the jawbone's breadth and volume to provide implants or other restorative procedures a solid base. This treatment is becoming more and more popular as a means of ensuring long-term survival and effective implant implantation. Additionally, ridge augmentation makes it feasible to increase alveolar volume, which promotes growth.
The North America market dominated the Global Dental Bone Grafts and Substitutes Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $434.7 million by 2028.The Europe market is exhibiting a CAGR of 7.8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 8.8% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/dental-bone-grafts-and-substitutes-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., Stryker Corporation, Institut Straumann AG, BioHorizons, Inc. (Henry Schein, Inc.), RTI Surgical, Inc., Geistlich Pharma AG (The Geistlich Group), Collagen Matrix, Inc. (Linden Capital Partners), and Dentium Co., Ltd.
By End-use
By Material Type
By Application
By Geography
Companies Profiled
Unique Offerings 
